Vijaya Ramesh Selected Research

Aftercare (After-Treatment)

1/2018

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vijaya Ramesh Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 11/2002
14	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 11/2003
12	Meningioma (Meningiomas) 01/2021 - 02/2008
6	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021 - 11/2004
5	Neurilemmoma (Schwannoma) 01/2021 - 08/2009
4	Neurofibromatoses (Neurofibromatosis) 01/2019 - 02/2010
2	Autism Spectrum Disorder 01/2020 - 03/2013
2	Carcinogenesis 01/2018 - 02/2008
2	Schwannomatosis 06/2017 - 03/2014
2	Chordoma 03/2009 - 09/2004
2	Hamartoma 09/2004 - 11/2003
2	Dystonia (Limb Dystonia) 05/2004 - 02/2003
1	Leukemia 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Tauopathies 01/2021
1	Neurodevelopmental Disorders 01/2020
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Epilepsy (Aura) 01/2020
1	Glioma (Gliomas) 06/2017
1	Neuroblastoma 06/2017
1	Sarcoma (Soft Tissue Sarcoma) 06/2017
1	Weight Gain 10/2015
1	Autistic Disorder (Autism) 03/2013
1	Cognitive Dysfunction 08/2008
1	Movement Disorders (Movement Disorder) 05/2004
1	Inflammation (Inflammations) 02/2003
1	Dystonia musculorum deformans type 1 02/2003
1	Neurologic Manifestations (Neurological Manifestations) 11/2002

Drug/Important Bio-Agent (IBA)

11	trans-sodium crocetinate (crocetin)IBA 01/2021 - 11/2003
11	Neurofibromin 2 (Merlin)IBA 01/2018 - 11/2004
11	Proteins (Proteins, Gene)FDA Link 07/2015 - 02/2003
8	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 03/2009
7	Sirolimus (Rapamycin)FDA Link 01/2020 - 08/2008
6	Tuberous Sclerosis Complex 2 ProteinIBA 01/2021 - 11/2002
5	Phosphotransferases (Kinase)IBA 01/2021 - 05/2012
4	Tuberous Sclerosis Complex 1 ProteinIBA 01/2021 - 11/2002
4	TOR Serine-Threonine KinasesIBA 01/2018 - 06/2008
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
3	Mechanistic Target of Rapamycin Complex 2IBA 01/2018 - 05/2012
3	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2015 - 11/2004
2	vistusertibIBA 01/2020 - 07/2015
2	EphA1 Receptor (Eph Receptor)IBA 01/2020 - 01/2018
2	Dasatinib (BMS 354825)FDA Link 01/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 02/2003
2	Mediator ComplexIBA 01/2015 - 11/2007
2	Biological ProductsIBA 08/2008 - 02/2008
2	radixinIBA 08/2005 - 11/2004
1	ChromatinIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	LigandsIBA 01/2021
1	brigatinibIBA 01/2021
1	Neuregulin-1 (Neuregulin 1)IBA 01/2021
1	NeuregulinsIBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Drug CombinationsIBA 01/2018
1	omipalisibIBA 01/2018
1	PanobinostatIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 06/2017
1	Uvitex SWN (SWN)IBA 06/2017
1	VimentinIBA 01/2016
1	MTOR InhibitorsIBA 07/2015
1	serum-glucocorticoid regulated kinaseIBA 07/2015
1	FRAX597IBA 07/2015
1	ElementsIBA 02/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2009
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 03/2009
1	TensinsIBA 03/2009
1	ezrinIBA 11/2004
1	moesinIBA 11/2004
1	Glutamic Acid (Glutamate)FDA Link 05/2004
1	KinesinsIBA 05/2004
1	Mitogen-Activated Protein KinasesIBA 02/2004

Therapy/Procedure

11	Therapeutics 01/2021 - 05/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 02/2010
1	Aftercare (After-Treatment) 01/2018